Company Filing History:
1 out of 340 
1 out of 1 Years Active: 2025
Title: Shoichi Maruyama: Innovator in Medical Detection Methods
Introduction
Shoichi Maruyama is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of systemic lupus erythematosus (SLE). His innovative approach aims to improve the accuracy of diagnosis while minimizing invasive procedures.
Latest Patents
Maruyama holds a patent for a method that detects whether a subject has systemic lupus erythematosus, specifically nephrotic syndrome, with high accuracy. The patent describes a process where the concentration of 3',4'-didehydro-3'-deoxycytidine in urine is measured and compared to a reference concentration. This method allows for the detection of SLE without the need for a renal biopsy, thus providing a less invasive diagnostic option.
Career Highlights
Throughout his career, Maruyama has been associated with prestigious institutions such as Keio University and the National University Corporation National Higher Education and Research System. His work has focused on advancing medical technology and improving patient outcomes through innovative diagnostic methods.
Collaborations
Maruyama has collaborated with notable colleagues, including Akiyoshi Hirayama and Tomoyoshi Soga. These partnerships have contributed to the development and refinement of his patented methods.
Conclusion
Shoichi Maruyama's contributions to medical diagnostics exemplify the impact of innovation in healthcare. His patented method for detecting systemic lupus erythematosus represents a significant advancement in non-invasive diagnostic techniques.